Skip to content
PICO Portalanswers from OpenAlex

Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer

PaperCitations, authors & open-access status

Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer have?

PICO Portalcitation count

Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer has 48 citations in the OpenAlex counts PICO Portal stores.

When was Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer published?

PICO Portalyear

Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer has 2023 year in the PICO Portal index.

What is the open-access status of Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer?

PICO Portaloa status

Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer has closed oa status in the PICO Portal index.

What is the DOI of Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer?

PICO Portaldoi

The DOI for Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer is on the source record.

What is the PMID of Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer?

PICO Portalpmid

The PMID for Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer is on the source record.

What is the OpenAlex record for Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer?

PICO Portalopenalex

The OpenAlex for Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial